Loading…
Loading…
NUVA (NuVasive, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
| LBPH | Longboard Pharmaceuticals, Inc. | $59.98 | $2.3B |
| DICE | DICE Therapeutics, Inc. | $47.55 | $2.3B |
| DCPH | Deciphera Pharmaceuticals, Inc. | $25.59 | $2.2B |
| CALT | Calliditas Therapeutics AB (publ) | $40.00 | $2.1B |
| ASTH | Astrana Health, Inc. | $38.41 | $1.9B |
| BLU | BELLUS Health Inc. | $14.75 | $1.9B |
| FUSN | Fusion Pharmaceuticals Inc. | $21.55 | $1.8B |
| AMAM | Ambrx Biopharma Inc. | $28.00 | $1.8B |
| HSKA | Heska Corporation | $119.99 | $1.3B |
| FNA | Paragon 28, Inc. | $13.09 | $1.1B |